ストックスクリーナーアプリを入手
3.58
9.82%
-0.39
アフターアワーズ：
3.60
0.02
+0.56%
Ataibeckley Inc (ATAI) 最新ニュース
5 Psychedelic Stocks to Buy Now - The Motley Fool
Guggenheim, JonesResearch Coverage and BPL-003 Control Might Change The Case For Investing In AtaiBeckley (ATAI) - simplywall.st
HC Wainwright remains bullish on AtaiBeckley Inc. (ATAI) - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A 219.60% Upside Potential In Innovative Mental Health Treatments - DirectorsTalk Interviews
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Guggenheim Initiates Buy Rating for AtaiBeckley (ATAI) With $11 PT, Cites Leadership in Psychiatry - Insider Monkey
H.C. Wainwright Remains Bullish on AtaiBeckley Inc. (ATAI) - Insider Monkey
Ataibeckley completes redomiciliation to the US - MSN
AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem With Over 200% Upside Potential - DirectorsTalk Interviews
Psychedelic: Analyst initiates Atai Beckley with Buy rating - TipRanks
Assessing AtaiBeckley (ATAI) Valuation After Recent Share Price Pullback - simplywall.st
Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... - Proactive Investors
Assessing AtaiBeckley (ATAI) Valuation After Trial Success Index Addition Capital Raise And US Move - Yahoo Finance
AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies - Proactive financial news
AtaiBeckley Weighs Late Stage Options After Milestones And US$300m Raise - simplywall.st
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data - Yahoo Finance
Guggenheim Initiates AtaiBeckley at Buy With $11 Price Target - marketscreener.com
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 - Finviz
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation - Finviz
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive financial news
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):